Table 2 KEGG pathway enrichment analysis (Top20)
Number | ID | Signaling Pathway | Enriched Gene Number | Number | ID | Signaling Pathway | Enriched Gene Number |
|---|---|---|---|---|---|---|---|
1 | hsa05417 | Lipid and atherosclerosis | 20 | 11 | hsa04914 | Progesterone-mediated oocyte maturation | 12 |
2 | hsa04010 | MAPK signaling pathway | 20 | 12 | hsa04659 | Th17 cell differentiation | 12 |
3 | hsa04151 | PI3K-Akt signaling pathway | 19 | 13 | hsa04068 | FoxO signaling pathway | 12 |
4 | hsa04014 | Ras signaling pathway | 17 | 14 | hsa05135 | Yersinia infection | 12 |
5 | hsa05415 | Diabetic cardiomyopathy | 15 | 15 | hsa04917 | Prolactin signaling pathway | 11 |
6 | hsa05205 | Proteoglycans in cancer | 15 | 16 | hsa05210 | Colorectal cancer | 11 |
7 | hsa04520 | Adherens junction | 13 | 17 | hsa01522 | Endocrine resistance | 11 |
8 | hsa05215 | Prostate cancer | 13 | 18 | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 10 |
9 | hsa04926 | Relaxin signaling pathway | 13 | 19 | hsa05133 | Pertussis | 9 |
10 | hsa05418 | Fluid shear stress and atherosclerosis | 13 | 20 | hsa05212 | Pancreatic cancer | 9 |